Developer docs
API playgroundTry for free, no card

Search company profiles

ACT Capital Management

Full company profile

uuid00356g7

Namestring
ACT Capital Management
Legal namestring
ACT Capital Management, LLC
Company typeenum
Private
Founded yearint
2003
Descriptiontext

ACT Capital Management, LLC is a privately held, SEC-registered investment adviser (CRD 307272) founded in 2003 and headquartered at 100 W. Lancaster Avenue, Suite 110, Wayne, Pennsylvania. The firm manages private hedge fund capital on behalf of institutional investors and qualified high-net-worth individuals, employing a long-biased long/short strategy concentrated in growth equities with a long-term time horizon.

The firm's investment focus is on publicly traded U.S. equities and select small private equity investments in companies with disruptive products, ideas, and innovation. Sector emphasis is BioPharma-centric and spans biopharmaceuticals/biotechnology/life sciences, medical technology and diagnostics, and artificial intelligence, cloud computing, and SaaS. The strategy uses concentrated positions in top ideas combined with extensive option writing to hedge, acquire, or exit positions, with a stated bullish bias toward medical and technological advancement.

ACT is a two-person operating firm. Amir L. Ecker serves as Founder, Managing Member, and Portfolio Manager with 30+ years of investment experience and 20+ years running the ACT strategy, while Fayth R. Ecker serves as Chief Compliance Officer, Fund Manager, and Member. Revenue is generated through management and performance fees on the single hedge fund vehicle, distributed exclusively through direct, relationship-based private placements with no retail or intermediary channel. There is no evidence of a technology platform, app, or API product; the firm's intellectual capital is its portfolio management expertise.

Short descriptiontext

ACT Capital Management is a privately held, SEC-registered investment adviser founded in 2003 in Wayne, Pennsylvania, managing private hedge fund capital for institutional and high-net-worth investors through a concentrated, long-biased long/short strategy focused on disruptive growth equities in biopharma, medtech, and AI/cloud/SaaS sectors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWayne, United States
HQ citystring
Wayne
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hedge fund management, growth equity investing, long-short strategy, biotech investment, alternative asset management
Industry2 codes
PRIMARYFSAHAAAC
Sector-Focused Equity Long/Short
SECONDARYFSAAAIAG
Sector/Thematic Equity (Active)
Financial & Insurance/Asset & Wealth Management/Asset Management — Equity (Active)
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Hedge Fund Management
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Hedge Fund Management
TypeSubscription Recurring
Description

Generates revenue through management fees and performance fees from managing private hedge funds. The firm manages concentrated positions in growth stocks with a long-term time horizon and employs extensive option writing strategies.

actcapitalmanagement.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Compliance or Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Private hedge fund investment - fee details in Form ADV
ModelOtherBilling cadenceAnnual
Notes

Fee structure details are located in ACT's Form ADV, accessible at adviserinfo.sec.gov. CRD Number: 307272.

actcapitalmanagement.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ACT Capital Management manages private hedge fund portfolios for institutional and qualified high-net-worth investors, primarily investing in publicly traded U.S. equities with small private equity investments. The strategy employs concentrated positions in top ideas across biopharmaceuticals, biotechnology, life sciences, medical technology, diagnostics, AI, cloud, and SaaS, using a long-biased long/short approach with extensive option writing to hedge, acquire, or exit positions.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ACT Capital Management offers a single unified investment management service for private hedge funds. The core offering consists of portfolio management focused on publicly traded U.S. equities and small private equity investments, with a long-term time horizon and a BioPharma-centric, long-biased long/short strategy. The firm targets growth stocks with disruptive products, ideas, and innovation across biopharmaceuticals, biotechnology, life sciences, medical technology, diagnostics, AI, cloud, and SaaS sectors.

Product and service1 record
1Private Hedge Fund Investment Management
CategoryHedge Fund Management
Description

Portfolio management services for private hedge funds, primarily investing in publicly traded U.S. equities with small private equity investments. The strategy holds concentrated long-term positions in top ideas, employs a BioPharma-centric long-biased long/short structure, and uses extensive option writing to hedge, acquire, or exit positions, targeting institutional and qualified high-net-worth investors.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global asset manager with active equity and alternative investment capabilities across multiple sectors. Comparable as a broad incumbent operating in the same overall asset management space, but not focused on ACT's specific biotech/AI niche.

2Baker Bros. Advisors
TypeDirect peer
Description

Long-standing biotech specialist running concentrated, long-biased public-equity and private-equity strategies. Highly comparable to ACT's concentrated, sector-focused equity model in life sciences.

TypeDirect peer
Description

Healthcare- and biotech-focused long/short fund with deep domain expertise and concentrated positions in disruptive life sciences companies. Directly comparable to ACT's biotech/medtech-focused long/short strategy.

TypeDirect peer
Description

Concentrated, long-duration technology and growth-equity investor with public-equity exposure to AI and cloud disruptors. Comparable to ACT's high-conviction, growth-stock-focused approach.

TypeDirect peer
Description

Biotech-focused long/short equity fund investing in disruptive therapeutic platforms. Comparable to ACT's concentrated, sector-specialist long/short approach in biopharmaceuticals.

TypeBroad incumbent
Description

Large diversified asset manager offering long/short and long-only equity strategies including sector-focused mandates. Comparable as a broad incumbent offering overlapping capabilities, but not specialist in ACT's niche sectors.

TypeDirect peer
Description

Biotech and healthcare-focused investment firm running long/short equity and credit strategies. Closely comparable to ACT's sector-focused, long-biased approach in life sciences and medical technology.

TypeDirect peer
Description

Healthcare-dedicated investment firm managing public-equity and private-equity strategies across biotech, medtech, and diagnostics. Comparable to ACT in sector specialization and long-term investment horizon.

TypeDirect peer
Description

Healthcare and biotech-focused long/short equity manager with concentrated positions in disruptive life sciences companies. Closely comparable to ACT's biotech-centric, long-biased strategy.

TypeDirect peer
Description

Technology-focused long/short equity manager with significant exposure to AI, cloud, and SaaS names. Comparable to ACT's AI/cloud/SaaS sector concentration and growth-oriented long/short structure.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ACT Capital Management

Hedge Fund Managementactcapitalmanagement.com

ACT Capital Management is a privately held, SEC-registered investment adviser founded in 2003 in Wayne, Pennsylvania, managing private hedge fund capital for institutional and high-net-worth investors through a concentrated, long-biased long/short strategy focused on disruptive growth equities in biopharma, medtech, and AI/cloud/SaaS sectors.

What ACT Capital Management does

ACT Capital Management, LLC is a privately held, SEC-registered investment adviser (CRD 307272) founded in 2003 and headquartered at 100 W. Lancaster Avenue, Suite 110, Wayne, Pennsylvania. The firm manages private hedge fund capital on behalf of institutional investors and qualified high-net-worth individuals, employing a long-biased long/short strategy concentrated in growth equities with a long-term time horizon.

The firm's investment focus is on publicly traded U.S. equities and select small private equity investments in companies with disruptive products, ideas, and innovation. Sector emphasis is BioPharma-centric and spans biopharmaceuticals/biotechnology/life sciences, medical technology and diagnostics, and artificial intelligence, cloud computing, and SaaS. The strategy uses concentrated positions in top ideas combined with extensive option writing to hedge, acquire, or exit positions, with a stated bullish bias toward medical and technological advancement.

ACT is a two-person operating firm. Amir L. Ecker serves as Founder, Managing Member, and Portfolio Manager with 30+ years of investment experience and 20+ years running the ACT strategy, while Fayth R. Ecker serves as Chief Compliance Officer, Fund Manager, and Member. Revenue is generated through management and performance fees on the single hedge fund vehicle, distributed exclusively through direct, relationship-based private placements with no retail or intermediary channel. There is no evidence of a technology platform, app, or API product; the firm's intellectual capital is its portfolio management expertise.

ACT Capital Management firmographics

Firmographics
Name
ACT Capital Management
Legal name
ACT Capital Management, LLC
Website
https://actcapitalmanagement.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
1–10 employees
Short description
ACT Capital Management is a privately held, SEC-registered investment adviser founded in 2003 in Wayne, Pennsylvania, managing private hedge fund capital for institutional and high-net-worth investors through a concentrated, long-biased long/short strategy focused on disruptive growth equities in biopharma, medtech, and AI/cloud/SaaS sectors.
Ownership category
akta.pro rank

ACT Capital Management industry classification

Industry
Product category
Hedge Fund Management
NAICS
Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSAHAAAC
Sector-Focused Equity Long/Short
SECONDARYFSAAAIAG
Sector/Thematic Equity (Active)
Financial & Insurance/Asset & Wealth Management/Asset Management — Equity (Active)

Keywords

  • Hedge fund management
  • Growth equity investing
  • Long-short strategy
  • Biotech investment
  • Alternative asset management

Where ACT Capital Management is headquartered

Location

Headquarters

HQ city
Wayne
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ACT Capital Management business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Compliance or Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Hedge Fund Management: Generates revenue through management fees and performance fees from managing private hedge funds. The firm manages concentrated positions in growth stocks with a long-term time horizon and employs extensive option writing strategies.

Pricing tiers

ModelBillingPrice
OtherAnnualPrivate hedge fund investment - fee details in Form ADV

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

ACT Capital Management product offering

Product offering

Core offering

ACT Capital Management manages private hedge fund portfolios for institutional and qualified high-net-worth investors, primarily investing in publicly traded U.S. equities with small private equity investments. The strategy employs concentrated positions in top ideas across biopharmaceuticals, biotechnology, life sciences, medical technology, diagnostics, AI, cloud, and SaaS, using a long-biased long/short approach with extensive option writing to hedge, acquire, or exit positions.

Product overview

ACT Capital Management offers a single unified investment management service for private hedge funds. The core offering consists of portfolio management focused on publicly traded U.S. equities and small private equity investments, with a long-term time horizon and a BioPharma-centric, long-biased long/short strategy. The firm targets growth stocks with disruptive products, ideas, and innovation across biopharmaceuticals, biotechnology, life sciences, medical technology, diagnostics, AI, cloud, and SaaS sectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Private Hedge Fund Investment Management Portfolio management services for private hedge funds, primarily investing in publicly traded U.S. equities with small private equity investments. The strategy holds concentrated long-term positions in top ideas, employs a BioPharma-centric long-biased long/short structure, and uses extensive option writing to hedge, acquire, or exit positions, targeting institutional and qualified high-net-worth investors.

Companies that use ACT Capital Management

Customer profile

Segments3 records

Ideal customer profiles1 record

ACT Capital Management technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

ACT Capital Management partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves3 records

Expansion highlights1 record

ACT Capital Management competitors and assessment

Company assessment

Broad incumbents

  • BlackRock: Global asset manager with active equity and alternative investment capabilities across multiple sectors. Comparable as a broad incumbent operating in the same overall asset management space, but not focused on ACT's specific biotech/AI niche.
  • Janus Henderson Investors: Large diversified asset manager offering long/short and long-only equity strategies including sector-focused mandates. Comparable as a broad incumbent offering overlapping capabilities, but not specialist in ACT's niche sectors.

Direct peers

  • Baker Bros. Advisors: Long-standing biotech specialist running concentrated, long-biased public-equity and private-equity strategies. Highly comparable to ACT's concentrated, sector-focused equity model in life sciences.
  • RA Capital Management: Healthcare- and biotech-focused long/short fund with deep domain expertise and concentrated positions in disruptive life sciences companies. Directly comparable to ACT's biotech/medtech-focused long/short strategy.
  • Altimeter Capital: Concentrated, long-duration technology and growth-equity investor with public-equity exposure to AI and cloud disruptors. Comparable to ACT's high-conviction, growth-stock-focused approach.
  • EcoR1 Capital: Biotech-focused long/short equity fund investing in disruptive therapeutic platforms. Comparable to ACT's concentrated, sector-specialist long/short approach in biopharmaceuticals.
  • Perceptive Advisors: Biotech and healthcare-focused investment firm running long/short equity and credit strategies. Closely comparable to ACT's sector-focused, long-biased approach in life sciences and medical technology.
  • OrbiMed Advisors: Healthcare-dedicated investment firm managing public-equity and private-equity strategies across biotech, medtech, and diagnostics. Comparable to ACT in sector specialization and long-term investment horizon.
  • Cormorant Asset Management: Healthcare and biotech-focused long/short equity manager with concentrated positions in disruptive life sciences companies. Closely comparable to ACT's biotech-centric, long-biased strategy.
  • Coatue Management: Technology-focused long/short equity manager with significant exposure to AI, cloud, and SaaS names. Comparable to ACT's AI/cloud/SaaS sector concentration and growth-oriented long/short structure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks5 records

Key highlights6 records

Customer concentration

ACT Capital Management financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ACT Capital Management leadership team

Management profile

Number of profiles

Profiles2 records

ACT Capital Management funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ACT Capital Management M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACT Capital Management

What does ACT Capital Management do?

ACT Capital Management manages private hedge fund portfolios for institutional and qualified high-net-worth investors, primarily investing in publicly traded U.S. equities with small private equity investments. The strategy employs concentrated positions in top ideas across biopharmaceuticals, biotechnology, life sciences, medical technology, diagnostics, AI, cloud, and SaaS, using a long-biased long/short approach with extensive option writing to hedge, acquire, or exit positions.

Is ACT Capital Management a public or private company?

ACT Capital Management is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ACT Capital Management founded?

ACT Capital Management was founded in 2003. It employs 1 to 10 people.

Where is ACT Capital Management based?

ACT Capital Management is headquartered in Wayne, United States, in the North America region.

How does ACT Capital Management make money?

One revenue line is on record: hedge Fund Management.

Who are ACT Capital Management's main competitors?

Broad incumbents on record are BlackRock and Janus Henderson Investors. Direct peers are Baker Bros. Advisors, RA Capital Management, Altimeter Capital, EcoR1 Capital, Perceptive Advisors, OrbiMed Advisors, Cormorant Asset Management and Coatue Management.

Does ACT Capital Management have an API?

No public API is recorded for ACT Capital Management.

What industry is ACT Capital Management in?

ACT Capital Management's product category is Hedge Fund Management. Its primary akta.pro industry code is FSAHAAAC, Sector-Focused Equity Long/Short, with a secondary code of FSAAAIAG, Sector/Thematic Equity (Active). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales